Biosynth Launches the First AquaSpark(TM) Products Stemming from Tel Aviv University Collaboration
AquaSpark™ molecules are the new generation of chemiluminescence probes for research and diagnostic applications. AquaSpark™ probes offer unique advantages as they can work as single agents, they have a higher efficiency and sensitivity over currently existing probes and they are especially designed to work under physiological conditions and can be used ex-vivo and in-vivo.
- (1888PressRelease) February 15, 2018 - STAAD, SWITZERLAND and TEL AVIV, ISRAEL - Only last August, Ramot at Tel Aviv University and BIOSYNTH AG announced their joint development work on novel detection molecules. The subject of this cooperation is the AquaSpark™ technology for chemiluminescence-based markers. They represent state-of-the-art technology and considerably improve the detection limits of diagnostic tests in comparison to existing conventional systems. Tel Aviv University’s Business Engagement Center, Ramot has filed a series of probes under the trademark name AquaSpark™. Biosynth received a license to manufacture and sell the AquaSpark™ probes.
Today, Biosynth announced that just after six months of intensive work together the first products have been launched. These are the most sensitive substrates for the detection of phosphatase activity on the world market today. Phosphatase is a widely-used enzyme in clinical diagnostics and basic research, a crucial component in antibody-based assays to visualize marker proteins for many diseases. Biosynth has launched two AquaSpark™ phosphatase substrates with different properties and price tags. These two options allow immunoassay manufacturers and research labs to achieve hitherto unique results in their applications.
About Biosynth:
Biosynth is an accomplished player with a successful history in the field of biochemicals for the diagnostics, pharmaceutical and chemical industries as well as food and environmental analysis. Biosynth 's own biology and chemistry labs constantly drive the further development of molecules for the sensitive detection of pathogens. In recent years Biosynth has successfully introduced innovative chromogenic, fluorogenic and luminescence-based systems into the field. The Swiss-based organization has branches in the USA, China and the EU as well as a worldwide distribution network that reaches the entire diagnostics industry. Biosynth, with its product offering of over 100’000 substances is a competent partner for industrial as well as research customers. www.biosynth.com
About Ramot
Ramot is the Business Engagement Center at Tel Aviv University, Israel's largest research and teaching university. Founded in 1956, Tel Aviv University is located in Israel's cultural, financial and industrial center. Rooted in both academic and corporate arenas, Ramot is uniquely positioned to cultivate the special relationships between these two compelling worlds, creating win-win connections that support fertile, ground breaking research while providing companies with discoveries that give them a crucial competitive edge. For more information, visit /www.ramot.org.
About Tel Aviv University
Tel Aviv University (TAU) - Israel's largest and most comprehensive institution of higher learning - is home to over 30,000 students studying in nine faculties and over 125 schools and departments across the spectrum of sciences, humanities and the arts. Situated in Israel's cultural, financial and technological capital, TAU shares Tel Aviv's unshakable spirit of openness and innovation – and boasts a campus life as dynamic and pluralistic as the metropolis itself. Tel Aviv the city and Tel Aviv the university are one and the same – a thriving Mediterranean center of diversity and discovery. Consistently ranked in the top 20 in the world in terms of scientific citations and among the top 100 universities internationally, Tel Aviv University is also Israel's first choice for students, and its graduates are the most sought after by Israeli companies. https://english.tau.ac.il/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam